A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision.
<h4>Background</h4>The complications inherent to conization include vaginal bleeding, cervical stenosis, amenorrhea, dysmenorrhea, and deep dyspareunia. Cervical stenosis is the most important complication due to the clinical repercussions. Studies show rates of cervical stenosis ranging...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0242067 |
| _version_ | 1818719326675402752 |
|---|---|
| author | Marcelo de Andrade Vieira Raphael Leonardo Cunha de Araújo Carlos Eduardo Mattos da Cunha Andrade Ronaldo Luis Schmidt Agnaldo Lopes Filho Ricardo Dos Reis |
| author_facet | Marcelo de Andrade Vieira Raphael Leonardo Cunha de Araújo Carlos Eduardo Mattos da Cunha Andrade Ronaldo Luis Schmidt Agnaldo Lopes Filho Ricardo Dos Reis |
| author_sort | Marcelo de Andrade Vieira |
| collection | DOAJ |
| description | <h4>Background</h4>The complications inherent to conization include vaginal bleeding, cervical stenosis, amenorrhea, dysmenorrhea, and deep dyspareunia. Cervical stenosis is the most important complication due to the clinical repercussions. Studies show rates of cervical stenosis ranging from 1.3 to 19% after the Loop Electrosurgical Excision Procedure (LEEP).<h4>Objective</h4>Our primary outcome was to compare the role of a new endocervical device to prevent cervical stenosis after LEEP in patients with high-grade squamous intraepithelial lesions (HSILs).<h4>Methods</h4>A randomized clinical trial was performed including phases II and III for evaluation of a new device for cervical stenosis prevention. In Phase II, we included 25 patients who underwent LEEP and placement of the device to assess its toxicity and efficacy. In phase III, we compared two groups (with and without the use of an anti-stenosis device) to evaluate its efficacy and safety.<h4>Results</h4>From August 2015 to June 2018, 265 participants were randomized (Phase II: 25, Phase III: 120 with DUDA and 120 without DUDA). The toxicity during phase II was observed in only one patient (4%) with pain grade > 7. There were 7 cases of toxicity during Phase III, 2 in the DUDA group (1.8%), and 5 in the No DUDA group (4.5%). The complications rate was numerically higher in the No DUDA group (2.5x higher) than the DUDA group, but this difference did not reach statistical significance (p = 0.52). The rate of cervical stenosis in DUDA group was (4-7,3%), and in No DUDA group was (4.3-5.8%) (p = 0.5). We did not find a significant difference when comparing the evolution at 3, 6, and 12 months in terms of cervical patency and visualization of the squamocolumnar junction (SCJ) during colposcopy. The DUDA group exhibited 15% to 19% nonvisualization of the SCJ, whereas that rate ranged from 10 to 12% in the No DUDA group.<h4>Conclusions</h4>The rate of cervical stenosis was not different comparing the use of a new device, specifically produced to prevent cervical stenosis, compared to no use after LEEP procedure. This clinical trial opens up space for a discussion of the utility of using cervical stenosis devices after LEEP. Perhaps in another type of conization it can be evaluated to avoid cervical stenosis. |
| first_indexed | 2024-12-17T20:05:10Z |
| format | Article |
| id | doaj.art-4144eb37f0d14ce690922d98d34bf507 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-17T20:05:10Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-4144eb37f0d14ce690922d98d34bf5072022-12-21T21:34:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024206710.1371/journal.pone.0242067A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision.Marcelo de Andrade VieiraRaphael Leonardo Cunha de AraújoCarlos Eduardo Mattos da Cunha AndradeRonaldo Luis SchmidtAgnaldo Lopes FilhoRicardo Dos Reis<h4>Background</h4>The complications inherent to conization include vaginal bleeding, cervical stenosis, amenorrhea, dysmenorrhea, and deep dyspareunia. Cervical stenosis is the most important complication due to the clinical repercussions. Studies show rates of cervical stenosis ranging from 1.3 to 19% after the Loop Electrosurgical Excision Procedure (LEEP).<h4>Objective</h4>Our primary outcome was to compare the role of a new endocervical device to prevent cervical stenosis after LEEP in patients with high-grade squamous intraepithelial lesions (HSILs).<h4>Methods</h4>A randomized clinical trial was performed including phases II and III for evaluation of a new device for cervical stenosis prevention. In Phase II, we included 25 patients who underwent LEEP and placement of the device to assess its toxicity and efficacy. In phase III, we compared two groups (with and without the use of an anti-stenosis device) to evaluate its efficacy and safety.<h4>Results</h4>From August 2015 to June 2018, 265 participants were randomized (Phase II: 25, Phase III: 120 with DUDA and 120 without DUDA). The toxicity during phase II was observed in only one patient (4%) with pain grade > 7. There were 7 cases of toxicity during Phase III, 2 in the DUDA group (1.8%), and 5 in the No DUDA group (4.5%). The complications rate was numerically higher in the No DUDA group (2.5x higher) than the DUDA group, but this difference did not reach statistical significance (p = 0.52). The rate of cervical stenosis in DUDA group was (4-7,3%), and in No DUDA group was (4.3-5.8%) (p = 0.5). We did not find a significant difference when comparing the evolution at 3, 6, and 12 months in terms of cervical patency and visualization of the squamocolumnar junction (SCJ) during colposcopy. The DUDA group exhibited 15% to 19% nonvisualization of the SCJ, whereas that rate ranged from 10 to 12% in the No DUDA group.<h4>Conclusions</h4>The rate of cervical stenosis was not different comparing the use of a new device, specifically produced to prevent cervical stenosis, compared to no use after LEEP procedure. This clinical trial opens up space for a discussion of the utility of using cervical stenosis devices after LEEP. Perhaps in another type of conization it can be evaluated to avoid cervical stenosis.https://doi.org/10.1371/journal.pone.0242067 |
| spellingShingle | Marcelo de Andrade Vieira Raphael Leonardo Cunha de Araújo Carlos Eduardo Mattos da Cunha Andrade Ronaldo Luis Schmidt Agnaldo Lopes Filho Ricardo Dos Reis A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. PLoS ONE |
| title | A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. |
| title_full | A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. |
| title_fullStr | A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. |
| title_full_unstemmed | A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. |
| title_short | A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision. |
| title_sort | randomized clinical trial of a new anti cervical stenosis device after conization by loop electrosurgical excision |
| url | https://doi.org/10.1371/journal.pone.0242067 |
| work_keys_str_mv | AT marcelodeandradevieira arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT raphaelleonardocunhadearaujo arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT carloseduardomattosdacunhaandrade arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT ronaldoluisschmidt arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT agnaldolopesfilho arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT ricardodosreis arandomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT marcelodeandradevieira randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT raphaelleonardocunhadearaujo randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT carloseduardomattosdacunhaandrade randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT ronaldoluisschmidt randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT agnaldolopesfilho randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision AT ricardodosreis randomizedclinicaltrialofanewanticervicalstenosisdeviceafterconizationbyloopelectrosurgicalexcision |